Видео ютуба по тегу Metsera

The fight over Metsera
The fight over Metsera
Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs
Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs
Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman
Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman
Бум искусственного интеллекта: проверка от Уолл-стрит | Сделка Pfizer и Metsera | Freedom Finance
Бум искусственного интеллекта: проверка от Уолл-стрит | Сделка Pfizer и Metsera | Freedom Finance
Pfizer to Buy Metsera for $4.9 Billion in Obesity Drug Bet
Pfizer to Buy Metsera for $4.9 Billion in Obesity Drug Bet
Ажиотаж вокруг поглощения Metsera (MTSR): начинается битва Pfizer против Novo против Lilly
Ажиотаж вокруг поглощения Metsera (MTSR): начинается битва Pfizer против Novo против Lilly
Metsera (MTSR): Their time is almost here
Metsera (MTSR): Their time is almost here
Obesity Update – September 30, 2025: Pfizer–Metsera deal, Roche CT-388, Lilly $6.5B and More
Obesity Update – September 30, 2025: Pfizer–Metsera deal, Roche CT-388, Lilly $6.5B and More
Pfizer’s $7.3B Metsera Buy Sparks Obesity Drug Revolution 2025-09-22...
Pfizer’s $7.3B Metsera Buy Sparks Obesity Drug Revolution 2025-09-22...
Pfizer vs Novo Nordisk: The $10 Billion Battle for Metsera and the Future of Weight Loss Drugs
Pfizer vs Novo Nordisk: The $10 Billion Battle for Metsera and the Future of Weight Loss Drugs
Mizuho's Holtz talks what is behind Novo's bid for Metsera
Mizuho's Holtz talks what is behind Novo's bid for Metsera
Wer bekommt MetSera? Milliardenschweres Wettbieten zwischen Pfizer und Novo Nordisk
Wer bekommt MetSera? Milliardenschweres Wettbieten zwischen Pfizer und Novo Nordisk
Novo Nordisk конкурирует с Pfizer в борьбе за биотехнологию в области лечения ожирения Metsera | ...
Novo Nordisk конкурирует с Pfizer в борьбе за биотехнологию в области лечения ожирения Metsera | ...
👁️ Once Monthly GLP-1 Beats Zepbound and Wegovy! (and it’s not Maritide)
👁️ Once Monthly GLP-1 Beats Zepbound and Wegovy! (and it’s not Maritide)
Pfizer wins $10 billion Metsera bidding war as Novo Nordisk exits | REUTERS
Pfizer wins $10 billion Metsera bidding war as Novo Nordisk exits | REUTERS
Metsera Weight-Loss Drug Shows Excellent Tolerability in Study | Obesity Breakthrough
Metsera Weight-Loss Drug Shows Excellent Tolerability in Study | Obesity Breakthrough
BMO's Seigerman on Pfizer-Metsera deal: Bullish as we've waited on Pfizer's foray into obesity
BMO's Seigerman on Pfizer-Metsera deal: Bullish as we've waited on Pfizer's foray into obesity
Lilly Ups Guidance as Novo, Pfizer Face Off in Obesity-Drug Tussle
Lilly Ups Guidance as Novo, Pfizer Face Off in Obesity-Drug Tussle
Pfizer CEO explains deal with Metsera Part 2 November 10 2025
Pfizer CEO explains deal with Metsera Part 2 November 10 2025
Генеральный директор Novo Nordisk: Мы уверены, что закроем сделку с Metsera
Генеральный директор Novo Nordisk: Мы уверены, что закроем сделку с Metsera
Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs
Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs
Pfizer vs. Novo Nordisk: The Battle for Metsera and the Future of Obesity Treatments
Pfizer vs. Novo Nordisk: The Battle for Metsera and the Future of Obesity Treatments
Pfizer and Novo Nordisk both raise bids for Metsera
Pfizer and Novo Nordisk both raise bids for Metsera
Pfizer files lawsuit over Metsera deal
Pfizer files lawsuit over Metsera deal
Pfizer Conference Call on Acquisition of Metsera | Sep 22, 2025
Pfizer Conference Call on Acquisition of Metsera | Sep 22, 2025